Managing Myeloma
- 2010-03-11 - News Flash: Unlocking Cancer Drug Mechanism May Avoid Risk of Birth Defects
- 2010-03-08 - Gregory Robert Mundy M.D. , Bone cancer research pioneer
- 2010-03-08 - Focal Lesions Found to Predict Multiple Myeloma Progression
- 2010-03-05 - ImmunoCellular Therapeutics Gets Notice of Allowance for New Patent
- 2010-03-05 - Living with Myeloma Conference Unites Patients, Families, Medical Experts
- 2010-03-03 - Æterna Zentaris' myeloma drug perifosine gets European positive opinion for orphan medicinal product status
- 2010-03-02 - ImmunoCellular Therapeutics Receives Notice of Allowance for a New Patent for its Antibody
- 2010-03-01 - Trends in the incidence and survival of multiple myeloma in South East England 1985-2004
- 2010-02-28 - Newsweek Journalist Andrew Jaffe dead at age 71
- 2010-02-26 - Channel 2's Blakley takes leave for cancer treatment [Chicago Sun Times]
- 2010-02-25 - Myeloma Canada calls on Quebec government to approve lenalidomide as second-line therapy
- 2010-02-24 - Myeloma Canada decries Quebec Government's limited approval of lenalidomide as third-line therapy
- 2010-02-17 - Mayo medical staff begins mobile lab visits in Northeast Florida
- 2010-02-16 - FDA MedWatch News Alert:Erythropoiesis-Stimulating Agents (ESAs): Procrit, Epogen and Aranesp: Drug Safety Communication
- 2010-02-15 - Board Recommends Continuation of Phase IIb Study of Vorinostat